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This poster presentation illustrates the birth of the post- war Japanese pharmaceutical 
industry through the emergence of the antibiotics sector during the American 
Occupation. At the end of the Second World War, much of Japans small pre-war 
pharmaceutical industry lay in ruins. Before World War II, pharmaceutical firms in 
Japan were primarily engaged in the distribution of imported Western medicines, 
readjusting dosages to adhere to domestic regulation. After the halt of German imports 
during World War I, however, government policy prompted some domestic production 
in vitamins, hormonal preparations, and sulfa drugs. While most of the physical capital 
was lost during the war, much of the human capital and networks from the pre-war 
industry survived. 
 
In the early years after World War II, the American Occupation was significant to 
antibiotics sector in the development and bridging of institutions and organizations that 
would enable antibiotic development, production, and distribution for the mass market. 
For the GHQ, enabling Japanese firms to mass-produce antibiotics offered a more cost-
effective means of public health administration and providing antibiotics to American 
troops in Japan. As a supra-governmental occupying power, the General Headquarters 
(GHQ) had authority over the Japanese government to decide and execute orders to 
guide an industry into existence. For example, the American military orchestrated and 
ensured successful technology transfers through seminars taught by leading scientists 
such as Jackson Foster, the delivery of effective strains of bacteria, and on-site 
consultations at production sites such as Morinaga and Banyu Pharmaceutical. It also 
set up a modern pharmaceutical education system, and established regulations such as 
the Pharmaceutical Affairs Law.  
 
The rapid development of the antibiotics sector between 1945 and 1952 helped to 
dramatically reduce the incidence of infectious disease in Japan. Thereafter, diseases of 
affluence became the primary concern. 
 
 
 
 
